MedTrace Logo

The Effect of the Nutraceutical "Hemofix" on the Coagulation System

NCT01651468 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-11-28

No results posted yet for this study

Summary

Hemofix is a herbal formula based on traditional Jewish and far eastern medicine created to assist in wound healing and bleeding arrest. It contains herbs such as Red Clover, Liquorice, Raspberry, Ginger and more. The present study will evaluate the formula on the coagulation system.

Conditions

  • Von Willebrand Disease
  • Menorrhagia

Interventions

DIETARY_SUPPLEMENT

HEMOFIX

unique complex herbal mixture

Sponsors & Collaborators

  • HEMOFIX

    collaborator UNKNOWN

  • Yocheved Grossman

    collaborator UNKNOWN

  • Idan Grossman

    collaborator UNKNOWN

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • David Varon, Prof · HMO

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-01-31
Completion
2023-12-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01651468 on ClinicalTrials.gov